This is a great strategic step. Since you don't have the dataset locally right now, stepping back to design the architecture and find a publishable "novelty" is exactly what we need to elevate this from a class project to an arXiv-worthy paper.

Let's break down the Old Approach vs. The Reality of the Problem, evaluate its Current State, and then design a Modern Publishable Pipeline with a clear novelty.

1. Evaluating the Old Approach (2023)
The Original Method: You were attempting to use an end-to-end Object Detector (Mask R-CNN / Faster R-CNN) to detect and bound malaria cells directly from the full blood smear images.

Why it was struggling (The Lackings):

The "Missing Annotation" Problem: As you noted, the dataset only had bounding boxes for some cells (likely just the infected ones or heavily obvious ones). Object detectors like Faster R-CNN treat anything without a bounding box as "background." When it sees a perfectly good unannotated red blood cell, it learns to suppress it. This is why many cells went unnoticed.
Dense Overlap Failure: Blood smear images have densely packed, overlapping cells. Standard bounding box detectors struggle heavily here because their Non-Maximum Suppression (NMS) layer often deletes boxes that overlap too much, assuming they are duplicate detections of the same object.
Outdated Tech Stack: Matterport's Mask R-CNN (the codebase you originally used) was built for TensorFlow 1.x. It's incredibly slow, difficult to maintain, and no longer impressive for publications.
Verdict: The old approach was standard for ~2018 but is highly flawed for dense medical imagery, especially when ground-truth labels are incomplete.

2. The Proposed Remodeled Architecture (Two-Stage Pipeline)
Your intuition to split this into two stages—Segmentation First, Classification Second—is exactly the right path. This eliminates the "missing bounding box" problem entirely.

Here is the publishable architecture:

Stage 1: Universal Cell Segmentation (Agnostic of Infection)
Instead of relying on your dataset's incomplete bounding boxes, we use a technique that guarantees every single cell is captured.

Approach: We use a Foundation Model for biological segmentation (like Cellpose or StarDist) or a highly tuned Traditional Computer Vision algorithm (Adaptive Watershed + Morphological operations).
Why it works: These models don't care if a cell is infected or not; their only job is to find the boundaries of any cell. This completely bypasses your incomplete ground-truth problem.
Output: Precise cropped images of every single individual cell in the blood smear.
Stage 2: Infection Classification
Approach: Now that we have perfectly cropped individual cells, we pass them through a lightweight, modern classifier (e.g., EfficientNetV2, ConvNeXt, or a Vision Transformer like ViT).
Why it works: The classifier only has to look at one cell at a time and ask: "Is this infected? If so, what stage (Ring, Trophozoite, Schizont)?"
Self-Supervised Labeling: We can map your original incomplete bounding box dataset to the cropped cells to train this classifier.
3. Finding the "Novelty" for an arXiv Publication
To publish on arXiv, we need an angle that makes this more than just "I used a classifier on malaria." Here are three potential novelties we can claim, based on your specific problem:

Novelty Angle 1: Overcoming Incomplete Annotations in Medical Datasets

The Pitch: Most deep learning pipelines fail when datasets have incomplete annotations (missing bounding boxes). We propose a decoupling framework where a Zero-Shot Biological Segmenter (like Cellpose) extracts robust Regions of Interest (ROIs), circumventing the missing label problem, followed by a dedicated classifier.
Why it's good: It solves a real-world problem. Researchers hate labeling thousands of cells. Proving your pipeline works despite bad/incomplete labels is highly publishable.
Novelty Angle 2: Handling Dense Overlapping Erythrocytes

The Pitch: Object detection bounding boxes fail on densely packed blood smears. By pivoting to an Instance Segmentation → Classification pipeline, we achieve a significantly higher recall rate on clumped cells than current state-of-the-art Faster R-CNN approaches.
Why it's good: You can directly compare Stage 1 (our approach) against your 2023 Mask R-CNN model and show a massive spike in detected cells.
Novelty Angle 3: Explainable AI (XAI) in the Classification Stage

The Pitch: If we use a Vision Transformer (ViT) or Grad-CAM on a CNN for the classification stage, we can output "Attention Maps" that visually highlight the malaria parasite inside the cropped cell crop.
Why it's good: The medical community strongly favors "Explainable AI." The paper becomes: "A Two-Stage Pipeline for Malaria Segmentation and Transparent Infection Classification."
Next Steps for Us
Since we don't have the dataset downloaded yet:

Which of the Novelty Angles sounds most interesting to you for the paper?
Once you decide, I can draft up the actual academic methodology outline in an artifact file so we can start building the codebase around that specific narrative.